ADHD

By Dave Muoio December 4, 2017
Boston-based Akili Interactive Labs has announced positive results from the largest clinical trial of its video game-based pediatric ADHD treatment yet. In light of these data, the company announced that it now plans to file AKL-T01, also known as Project: Evo ADHD Treatment, for FDA clearance as a novel treatment for children and adolescents with ADHD “This is, any way you slice it, our largest...
By Jonah Comstock September 15, 2017
A brain-training video game shows promising signs for the treatment of ADHD in a new randomized clinical trial. In the game, from developer NeuroPlus, children wear an EEG monitor and additional sensors that measure movement and muscle tension. The readings from those sensors actually control the game — in one game, the player rides a dragon that speeds up the more they focus and slows down when...
By Heather Mack March 6, 2017
Japanese digital health company Welby has collaborated with Janssen, a pharmaceutical division of Johnson & Johnson, to develop a mobile app for people with attention deficit hyperactivity disorder, or ADHD. The app will be available on iOS and Android throughout Japan. Aozora, the task management app, was created by Welby and will be distributed by Janssen to people with ADHD who are...
By Aditi Pai March 3, 2015
Boston-based Akili Interactive Labs has partnered with Delivering Scientific Innovation for Autism (DELSIA), a not-for-profit subsidiary of Autism Speaks. DELSIA is funding an efficacy study of Akili's iOS-based game, called Project: EVO, with children that have high-functioning autism and ADHD. The trial will be a blind, randomized, placebo-controlled study "that will look to measure cognitive...
By Aditi Pai March 3, 2015
Chrono Therapeutics, a Hayward, California-based company working on a new wearable for smoking cessation and drug delivery,  has received an investment from seed fund Rock Health. According to MedCity News, Rock Health has contributed $100,000. This brings the company's total funding to about $32.1 million. Chrono disclosed its most recent round in June 2014. It included contributions from Canaan...
By Aditi Pai January 9, 2014
Boston-based Akili Interactive Labs partnered with Pfizer to conduct a study of Akili's iOS-based game, Project Evo, in the hopes of using the game to detect indications of Alzheimer's in healthy individuals. The month-long study of 100 participants includes a mix of some who have risk markers of potentially developing Alzheimer's and some who do not. All participants will take the game home and...